UCB says gets EU clearance for Cimzia in psoriatic arthritis

[riky]

UCB says gets EU clearance for Cimzia in psoriatic arthritis

BRUSSELS (Reuters) - Belgian pharmaceutical group UCB said on Friday that European regulators have recommended approval of its Cimzia drug for treating psoriatic arthritis in adults. UCB said that the condition affected an estimated 24 out of 10,000 people, usually between the ages of 30 and 50, and up to 30 percent of psoriasis patients. The news follows the approval by the European Medicine Agency's Committee for Medical Products for Human Use (CHMP) for Cimzia to treat adults with severe active axial spondyloarthritis. ...

Source: You are not allowed to view links. Register or Login